Literature DB >> 2103574

Aromatase activity in genital skin fibroblasts from normal and androgen-insensitive individuals.

S C Stillman1, B A Evans, I A Hughes.   

Abstract

Human genital skin fibroblasts were used to study aromatase activity by analysing the [3H]H2O released as [1 beta-3H]androstenedione is converted to oestrone. 4-Hydroxyandrostenedione was shown to be a competitive inhibitor of this aromatase activity, the concentration of inhibitor producing 50% inhibition being 1.29 nmol/l. Dexamethasone stimulated the enzyme complex in a dose-dependent manner with half-maximal stimulation at 11.5 nmol/l. A peak of induction occurred after 16 h of preincubation. Measurement of aromatase activity in normal cell strains provided a normal range for the Michaelis-Menten constant (Km) and the maximum velocity (Vmax) of 6.72 +/- 0.54 nmol/l and 215.3 +/- 33.9 fmol/mg protein per h (mean +/- S.E.M., n = 20) respectively. Km values obtained for partial and complete androgen insensitivity syndrome (PAIS and CAIS) patient cell strains were all within the normal range. The mean Vmax +/- S.E.M. in cell strains from patients with PAIS (n = 13) and CAIS (n = 11) were 127.4 +/- 19.2 and 54.8 +/- 19.3 fmol/mg protein per h respectively. Vmax values for patients with CAIS were significantly (P less than 0.001) lower than normal subjects. This suggests that aromatase expression in genital skin fibroblasts is androgen-dependent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2103574     DOI: 10.1677/joe.0.1270177

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  3 in total

1.  Recurrent severe hyperandrogenism during pregnancy: a case report.

Authors:  H B Holt; S Medbak; D Kirk; R Guirgis; I Hughes; M H Cummings; D R Meeking
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

Review 2.  Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.

Authors:  L R Wiseman; D McTavish
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

3.  In vitro effect of hCG on steroidogenesis in the testicular tissue from a patient with complete androgen resistance.

Authors:  A M Ronco; L E Valladares; L Devoto; A Ahumada; A M Pino
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.